Additionally, the inhibition of PRMT5 by the small-molecular inhibitor EPZ015666 was shown to induce apoptosis, regulate cell cycle progression, and reduce mammosphere formation both in vitro and in vivo, with its administration significantly impeding tumor progression in a patient-derived xenograft model. The gene discussed is PRMT5; the disease is neoplasm.